{
    "clinical_study": {
        "@rank": "90700", 
        "arm_group": [
            {
                "arm_group_label": "Saline+glucose nasal spray", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A nasal spray with isotone saline + 5% glucose, dosing one puff 5 times daily in each nostril at the first treatment day and thereafter trice daily for a total of one week"
            }, 
            {
                "arm_group_label": "Nasal spray with glucose oxidase+glucose", 
                "arm_group_type": "Active Comparator", 
                "description": "A nasal spray with 200U/ml of glucose oxidase + 5% glucose. Treatment starts with 5 puffs in each nostril at the first day, and thereafter trhee times daily for a total treatment time of one week."
            }
        ], 
        "brief_summary": {
            "textblock": "Healthy persons are invited to participate in the study and are given a home protocol\n      (WURSS21), nasal spray and a sample pin. The included persons are told to make a\n      nasopharyngeal sampling from the nose when they are sure that they have caught a common\n      cold. After the sampling they start to spray and also fill in the records daily. The aim of\n      the study is to investigate whether a nasal spray with glucose oxidase could shorten an\n      episode of common cold."
        }, 
        "brief_title": "A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Reducing Symptoms of a Common Cold", 
        "condition_browse": {
            "mesh_term": "Common Cold"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy adults\n\n        Exclusion Criteria:\n\n          -  Ongoing allergy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01883453", 
            "org_study_id": "GOcoldU&B2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nasal spray with glucose oxidase+glucose", 
                "description": "A hydrogen peroxide producing enzyme", 
                "intervention_name": "Glucose oxidase+glucose", 
                "intervention_type": "Other", 
                "other_name": "Nasal spray containing saline solution+glucose oxidase+5%glucose"
            }, 
            {
                "arm_group_label": "Saline+glucose nasal spray", 
                "description": "Isotonic saline + 5% glucose in a bag-on-valve nasal spray device", 
                "intervention_name": "Saline+glucose", 
                "intervention_type": "Other", 
                "other_name": "Nasal spray with isotonic saline + 5% glucose"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 24, 2013", 
        "location": [
            {
                "contact": {
                    "email": "liselott.tano@mil.se", 
                    "last_name": "Liselott Tano, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Boden", 
                        "country": "Sweden"
                    }, 
                    "name": "F\u00f6rsvarsh\u00e4lsan"
                }, 
                "investigator": {
                    "last_name": "Liselott Tano, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "christer.malm@idrott.umu.se", 
                    "last_name": "Christer Malm, Associate professor"
                }, 
                "facility": {
                    "address": {
                        "city": "Ume\u00e5", 
                        "country": "Sweden"
                    }, 
                    "name": "Idrottsmedicin"
                }, 
                "investigator": {
                    "last_name": "Christer Malm, Associate professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Double Blinded Clinical Study Aiming to Shorten an Episode of Common Cold When the Treatment is Started at the Onset of an Episode of Common Cold", 
        "overall_contact": {
            "email": "krister.tano@nll.se", 
            "last_name": "Krister Tano, MD, PhD", 
            "phone": "00465569043"
        }, 
        "overall_official": {
            "affiliation": "Ume\u00e5 University", 
            "last_name": "Krister Tano, MD,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Committee of Ethics", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Using the Wisconsin Upper Respiratory Symptom Score (WURSS-21)it is possible to assess if a nasal spray containing glucose oxidase and glucose would be able to reduce symptoms of a common cold", 
            "measure": "Reducing symptoms of a common cold", 
            "safety_issue": "Yes", 
            "time_frame": "One week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01883453"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ume\u00e5 University", 
            "investigator_full_name": "Krister Tano", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ume\u00e5 University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ume\u00e5 University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}